Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocortisone added to anesthesia regimens in conservative breast cancer surgery
PACTR201304000509378Completed
- Sponsor
- Medical Research Institute
- Start
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of hydrocortisone in breast cancer (4 arms), sponsored by Medical Research Institute. Primary endpoint: Postoperative serum interleukin-6 level decrease. Started Mar 2013; status: completed.
02
Drugs
hydrocortisone
03
Conditions
breast cancer
Beyond the preview
Go deeper on PACTR201304000509378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201304000509378.